Risk Reduction of Gastric Cancer by Aspirin: In the Quest of the Holy Grail

Am J Gastroenterol. 2019 Mar;114(3):533. doi: 10.14309/ajg.0000000000000055.

Authors

Zhiqing He¹, Ru Ding¹, Feng Zhang², Zonggui Wu¹, Chun Liang¹

Affiliations

¹ Department of Cardiology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
² Department of Pharmacy, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.

PMID: 30676369
DOI: 10.14309/ajg.0000000000000055

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aspirin*
Risk Reduction Behavior*

Substances

Aspirin